IRIS
PLANTONE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.950
NA - Nord America 1.443
AS - Asia 210
SA - Sud America 9
AF - Africa 6
OC - Oceania 5
Totale 3.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.430
IE - Irlanda 642
RU - Federazione Russa 286
SE - Svezia 283
IT - Italia 230
FR - Francia 169
SG - Singapore 149
GB - Regno Unito 128
ES - Italia 90
FI - Finlandia 32
DE - Germania 24
BE - Belgio 15
CZ - Repubblica Ceca 13
CA - Canada 12
CN - Cina 12
IN - India 7
HK - Hong Kong 6
NL - Olanda 6
TR - Turchia 6
BR - Brasile 5
HU - Ungheria 5
SA - Arabia Saudita 5
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 4
PT - Portogallo 4
ZA - Sudafrica 4
JP - Giappone 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CI - Costa d'Avorio 2
CL - Cile 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MY - Malesia 2
RO - Romania 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
ID - Indonesia 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.623
Salva come PNG Salva come JPEG
Città #
Dublin 638
Chandler 378
Princeton 165
Fairfield 143
Singapore 104
Southend 88
Málaga 87
Wilmington 84
Moscow 53
Ashburn 50
Seattle 36
Woodbridge 35
San Diego 33
Siena 31
Houston 30
Ann Arbor 29
Helsinki 27
Milan 27
Cambridge 26
London 18
Florence 17
Brussels 14
Rome 14
Brno 13
Lucca 12
Livorno 11
Toronto 9
Pisa 8
San Francisco 8
New York 7
Norwalk 7
Sarzana 7
Naples 6
Santa Clara 6
Budapest 5
Lappeenranta 5
Riyadh 5
Shanghai 4
Columbus 3
Cormano 3
Enfield 3
Fremont 3
Lisbon 3
Newark 3
Newham 3
Nuremberg 3
Sesto San Giovanni 3
São Paulo 3
Abidjan 2
Albany 2
Almaty 2
Amsterdam 2
Ascoli Piceno 2
Barcelona 2
Bathurst 2
Beijing 2
Bergamo 2
Bern 2
Bologna 2
Breganze 2
Chicago 2
Deiva Marina 2
Delhi 2
Dortmund 2
Durban 2
Eastham 2
Frankfurt am Main 2
Fucecchio 2
Hong Kong 2
Hounslow 2
Johannesburg 2
Kilburn 2
Kudrovo 2
La Spezia 2
Messina 2
Mumbai 2
Munich 2
Palermo 2
Redmond 2
Riga 2
Rio de Janeiro 2
San Bruno 2
Tehran 2
Tokyo 2
Yerevan 2
Adelaide 1
Amelia 1
Auckland 1
Baku 1
Bangkok 1
Belgrade 1
Berlin 1
Bishkek 1
Bogotá 1
Brasov 1
Bratislava 1
Brookline 1
Brooklyn 1
Cagliari 1
Central 1
Totale 2.359
Salva come PNG Salva come JPEG
Nome #
Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders 70
Neurological diseases associated with autoantibodies targeting the voltage-gated potassium channel complex: immunobiology and clinical characteristics 64
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 63
Atlantoaxial subluxation in rheumatoid arthritis 59
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 58
Brain perfusion by arterial spin labeling MRI in multiple sclerosis 58
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis 58
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 57
Anorexia Heralding the Onset of Neuromyelitis Optica 57
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 56
Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases 56
Association between Anemia and Multiple Sclerosis 56
Amiloride, Fluoxetine or Riluzole to Reduce Brain Volume Loss in Secondary Progressive Multiple Sclerosis: The MS-SMART Four-Arm RCT 55
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis 55
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 55
Acute Necrotizing Encephalopathy during Novel Influenza A (H1N1) Virus Infection 55
CD4(+)T-bet(+), CD4(+)pSTAT3(+) and CD8(+)T-bet(+) T cells accumulate in peripheral blood during NZB treatment 54
Paroxysmal ataxia and dysarthria in multiple sclerosis 53
B Lymphocytes in Alzheimer's Disease-A Comprehensive Review 52
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer 52
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 51
Acute refractory intestinal pseudo-obstruction in MELAS : Efficacy of prucalopride 50
Teaching NeuroImages: Basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies 50
A case of hemorrhagic Wernicke's encephalopathy following gastric surgery 48
Interferon-beta therapy and risk of thrombocytopenia in multiple sclerosis patients 48
Retinal nerve fibre layer thickness in the temporal quadrant predicts clinical disability and cervical cord cross sectional area in secondary progressive multiple sclerosis 48
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 47
Tumefactive Demyelinating Lesions and Pregnancy 47
A neurometabolic profile of SPMS: the relationship between brain metabolites and clinical disability 47
Midbrain Panda Sign in a Patient with Wilsons Disease 46
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients 46
PPIs as possible risk factor for copper deficiency myelopathy 45
A longitudinal study of spinal cord atrophy in progressive multiple sclerosis 45
A Neurometabolic Profile of Secondary Progressive Multiple Sclerosis: The Relationship between Brain Metabolites and Clinical Disability 45
Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report 44
Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients 44
The detection of neural autoantibodies in patients with antiepileptic- drug-resistant epilepsy predicts response to immunotherapy 44
Concurrence of multiple sclerosis and brain tumors 44
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study 44
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review 43
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 43
Initial cross-sectional MR spectroscopy analysis of a cohort of secondary progressive MS patients enrolled in the MS-SMART trial 43
CD8+effector and memory T cell subsets in relapsing-onset Multiple Sclerosis 43
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 43
Spinal Cord Atrophy in Multiple sclerosis 42
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations 42
HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence 42
Optical coherence tomography in secondary progressive multiple sclerosis: a baseline data report from the MS-SMART trial 41
HIV and lower risk of multiple sclerosis: role of adaptive immune response 41
Reply [a: Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E] 40
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet 39
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 39
Striatum Involvement in LGI1 Limbic Encephalitis 39
Pure psychiatric presentation in a patient with Fahr's disease 39
Neuroimaging Correlates of Longitudinally Extensive Transverse Myelitis in AQP4-IgG Positive and AQP4-IgG Negative Patients 39
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview 38
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial 38
Vitamin D in neurological diseases 37
Dimethyl fumarate may still have a role in progressive multiple sclerosis 37
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis 37
Natural killer lymphocytes in HIV and multiple sclerosis 37
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 36
Neuroradiological characterization of multiple sclerosis patients with chronic pain 35
Systematic assessment and characterization of chronic pain in multiple sclerosis patients: preliminary results 35
Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS 35
Increased CD4(+)CD25(+)Foxp3(+) T cells in peripheral blood of celiac disease patients: Correlation with dietary treatment 34
Teaching NeuroImages: A case of hearing loss in a paraneoplastic syndrome associated with anti-Hu antibody 34
MTR-derived pial and subpial abnormalities in the spinal cord of RRMS patients: a two-year follow-up study 34
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 33
T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity 33
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors 33
Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis 33
Exploring cognition in secondary progressive multiple sclerosis (SPMS) 33
Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis 33
Focal Hyperhidrosis in Tumefactive Multiple Sclerosis 32
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 31
Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumab 31
Osteoma of the Internal Auditory Canal 30
Copper deficiency myelopathy: A report of two cases 30
Distinct lymphocyte subsets in IgM-related neuropathy: clinical-immunological correlations 30
Secondary Progressive Multiple Sclerosis: Definition and Measurement 29
Type 1 immune response in progressive multiple sclerosis 28
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis 28
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 27
Involvement of type I immune responses in swine-origin H1N1 influenza virus infection 27
Stroke in critically ill patients 25
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 24
Trigeminal Neuralgia Associated With a Solitary Pontine Lesion: A Case Report 24
Is There a Role of Vitamin D in Alzheimer's disease? 23
Riboflavin in Neurological Diseases: A Narrative Review 21
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis 19
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 16
Serum neurofilament light chain and small fiber neuropathy: Every cloud has a silver lining 15
Inflammatory profile in mitochondrial diseases: a cohort study 14
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments 13
Psychological General Well-being, Cognitive Failure, and Inflammation Biomarkers Among Workers 4 Months After a Mild/Asymptomatic SARS-CoV-2 Infection 12
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review 12
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 10
Brain reserve and physical disability in secondary progressive multiple sclerosis 9
A new national survey of centers for cognitive disorders and dementias in Italy 7
Totale 3.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 290 214 59 22 7 90 43 29 76 302
2022/20231.358 133 129 174 170 81 249 45 82 152 94 24 25
2023/2024840 44 28 35 21 18 223 288 14 5 18 20 126
2024/2025593 88 148 170 133 54 0 0 0 0 0 0 0
Totale 3.923